Terraflora Daily Care and Gastrointestinal Health
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- OvationLab
- Study ID
- NCT07355634
- Status
- Recruiting
Conditions
- Gastrointestinal
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Synbiotic Dietary Supplement — DIETARY_SUPPLEMENT12 weeks of supplementation with Enviromedica - Terraflora Daily Care
- Placebo — DIETARY_SUPPLEMENTPlacebo capsule
Study Details
A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.
Key Dates
- Start date
- Jan 12, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Terraflora - Daily Care
- Placebo Comparator: Placebo
Primary Outcome Measure
GA-Map Dysbiosis on GI360 Profile [ Time Frame: 4 weeks, 12 weeks ]
Central Contacts
- Chris D'Adamo, Ph.D.240-232-2103
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OvationLab | Richmond | Virginia | 23220 |
Find similar trials in Richmond, VA
By research site
Related Studies
- A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight IndividualsEnrolling By Invitation · ClostraBio Inc. · Los Angeles, California